GBA1 and Parkinson disease: The deficiency of glucocerebrosidase impairs the clearance of α-synuclein, a central protein in PD’s pathogenesis, promoting its aggregation into Lewy bodies, synaptic dysfunction, and neurotoxicity [19,20,21,22].